China Healthcare Sector Report 2018 1st Quarter

In Q4 2017, the government expenditure on health and family planning was RMB 276.7bn, representing a decrease of 7.5% y/y. Nevertheless, the healthcare expenditure in urban area was RMB 453.9bn, up by 2.8% y/y. For the whole year 2017, the government expenditure on healthcare was RMB 1,445bn, up by 9.8% y/y. The healthcare sector in China continued to attract substantial investment, both domestic and private and the investments in the sector continued to increase at a double-digit pace. In Q4 2017, the fixed asset investment in the sector was RMB 157.5bn, representing an increase of 14.8% compared to that in the same quarter of the previous year. The accumulated fixed asset investment in China’s healthcare sector for the whole year 2017 was RMB 524.3bn. The foreign direct investment rose by an even faster pace of 20.1% y/y to USD 305.2 mn. 

This report provides a complete and detailed analysis of the healthcare sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the healthcare sector in China
• Access forecasts for growth in the sector
• View key data on healthcare spending and health insurance in China
• Crystallise the forces both driving and restraining this sector in China
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in China
• Build a clear picture of trends and issues for sub-sectors (e.g. medical institutions, medical devices and pharmaceuticals).

See below for a complete table of report contents: